{
    "organizations": [],
    "uuid": "d5cd3d13d80213a401e2c5d51a7fcd23fc5bfc72",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-antares-pharma-provides-xyosted-re/brief-antares-pharma-provides-xyosted-regulatory-update-idUSASC09TQT",
    "ord_in_thread": 0,
    "title": "BRIEF-Antares Pharma Provides Xyosted™ Regulatory Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Antares Pharma Inc:\n* ANTARES PHARMA PROVIDES XYOSTED™ REGULATORY UPDATE * BELIEVES THAT IT DOES NOT NEED TO CONDUCT ANY NEW CLINICAL STUDIES TO SUPPORT RESUBMISSION\n* ANTARES PHARMA -ANTICIPATES RESUBMISSION TO INCLUDE RE-ANALYSES OF EXISTING DATA, ADDRESS LABELING, POTENTIAL POST-APPROVAL RISK MITIGATION STRATEGIES\n* ANTICIPATES SUBMITTING COMPLETE RESPONSE IN Q2 OF THIS YEAR\n* OFFICIAL MINUTES FROM TYPE A MEETING WITH FDA ON FEB. 21 HAVE BEEN RECEIVED Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-27T19:48:00.000+03:00",
    "crawled": "2018-03-28T19:14:12.024+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "antares",
        "pharma",
        "inc",
        "antares",
        "pharma",
        "provides",
        "regulatory",
        "update",
        "belief",
        "need",
        "conduct",
        "new",
        "clinical",
        "study",
        "support",
        "resubmission",
        "antares",
        "pharma",
        "resubmission",
        "include",
        "existing",
        "data",
        "address",
        "labeling",
        "potential",
        "risk",
        "mitigation",
        "strategy",
        "anticipates",
        "submitting",
        "complete",
        "response",
        "q2",
        "year",
        "official",
        "minute",
        "type",
        "meeting",
        "fda",
        "received",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}